1.83  0.14 (8.28%)		10-06 16:00
Open: 1.72 High: 1.83 Volume: 589,363		Pre. Close: 1.69 Low: 1.66 Market Cap: 84(M)

Short term
Mid term
Targets	6-month :	2.32	1-year :	2.73
Resists	First :	1.98	Second :	2.33
Pivot price	1.77
Supports	First :	1.41	Second :	1.18
MAs	MA(5) :	1.76	MA(20) :	1.83
	MA(100) :	1.54	MA(250) :	0.88
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	44.6	D(3) :	40.5
RSI	RSI(14): 48.1
52-week	High :	3.24	Low :	0.27

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ HYFT ] has closed below upper band by 38.8%. Bollinger Bands are 43.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	1.83 - 1.84	1.84 - 1.85
Low:	1.64 - 1.65	1.65 - 1.66
Close:	1.81 - 1.83	1.83 - 1.84

An AI‑driven Bio‑Native therapeutics company whose LENSai™ platform—powered by HYFT® technology—integrates multi‑omics and AI for advanced biologics discovery. Previously operating as ImmunoPrecise Antibodies, the company has rebranded and repositioned as MindWalk, transitioning from wet‑lab services toward SaaS, DaaS, generative biologics, and strategic partnerships.

Tue, 23 Sep 2025
MindWalk Holdings Corp. (HYFT) Surges with 45% Revenue Growth and Strategic AI-Focused Rebrand - Yahoo Finance

Mon, 22 Sep 2025
MindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and Longevity - The AI Journal

Tue, 16 Sep 2025
How MindWalk Holdings' Rebranding and Improved Earnings May Impact HYFT Investors - Yahoo Finance

Tue, 16 Sep 2025
MindWalk Holdings Corp (HYFT) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance

Mon, 15 Sep 2025
MindWalk Holdings Corp. Reports Earnings Results for the First Quarter Ended July 31, 2025 - MarketScreener

Mon, 15 Sep 2025
MindWalk Holdings Reports Record Revenue and Strategic Divestiture - TipRanks

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	46 (M)
Shares Float	42 (M)
Held by Insiders	9 (%)
Held by Institutions	8.6 (%)
Shares Short	453 (K)
Shares Short P.Month	725 (K)

EPS	-0.61
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.44
Profit Margin	-115.9 %
Operating Margin	-131.6 %
Return on Assets (ttm)	-14.6 %
Return on Equity (ttm)	-112.4 %
Qtrly Rev. Growth	27.7 %
Gross Profit (p.s.)	0.3
Sales Per Share	0.54
EBITDA (p.s.)	-0.21
Qtrly Earnings Growth	0 %
Operating Cash Flow	-9 (M)
Levered Free Cash Flow	-18 (M)

PE Ratio	-3.05
PEG Ratio	0
Price to Book value	4.06
Price to Sales	3.35
Price to Cash Flow	-9.6

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.